Medical Devices Startups

Cyta Therapeutics develops polymer-based nanogel therapeutics (IntelliGels) to treat obesity, NASH, type 2 diabetes, and metabolic disorders. The company's lead program, Cyta-001, is a liver-targeted drug delivery system encapsulating a thyroid hormone receptor agonist for metabolic disease management.

1 investor

Cytodyme builds software for regulatory and quality teams at life science companies to manage post-market reporting, literature reviews, documentation, audits, and submissions. The platform consolidates data from disconnected systems to reduce administrative burden for regulated life science and biotech teams.

1 investor

Cytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.

1 investor

Cytomos develops AuraCyt®, a microelectronics-based biotechnology platform for real-time single-cell analytics in bioprocessing and cell and gene therapy manufacturing. The company serves large biotech and pharma companies seeking cost-effective process analytical technology solutions for drug development and manufacturing.

1 investor

Cytos is an orthobiologics company that develops biologic treatments for orthopedic conditions. The company serves orthopedic surgeons and patients requiring spine, foot, ankle, and other orthopedic interventions.

1 investor

Cytovation develops immunotherapy treatments designed to enhance immune response against various cancer types, with a focus on engineered synthetic peptides and first-in-class therapeutic candidates. The company is built on research foundations from Norwegian academic institutions and serves oncology and immunology markets.

1 investor

Cytrellis develops medical device technologies focused on aesthetic and reconstructive treatments, with expertise spanning dermatology, plastic surgery, and wound healing applications.

1 investor

Cytura Therapeutics is a pharmaceutical company focused on drug discovery and development, with backing from academic research institutions and venture capital firms specializing in biotech and medtech investments.

1 investor

D2B3 develops proprietary drug delivery technology that temporarily relaxes the blood-brain barrier to enable therapeutic targeting of central nervous system diseases. The platform is designed to work across multiple drug classes for treating brain-related disorders.

1 investor

Dalent Medical develops medical devices for Ear, Nose & Throat (ENT) physicians. The company is based in Miami.

1 investor

Dalriada is a contract research organization providing integrated small molecule drug discovery services for global biotech and pharmaceutical companies. The company operates an interdisciplinary team under one roof offering full-suite drug discovery expertise from target identification through pre-clinical development.

1 investor

Damae Medical develops deepLive, a non-invasive skin imaging system based on LC-OCT (Line-field Confocal Optical Coherence Tomography) that produces 3D histology-like and confocal-like images of skin tissue. The device is used by dermatologists to image and assess skin conditions including melanoma and carcinoma.

1 investor

Damora Therapeutics develops targeted monoclonal antibody therapies for rare blood disorders, specifically Essential Thrombocythemia and Myelofibrosis driven by mutant calreticulin mutations. The company is advancing novel subcutaneous biologics to treat approximately 42,000 U.S. patients with these myeloproliferative neoplasms.

1 investor

Danaher is a global science and technology company specializing in biotech, diagnostics, and life sciences with businesses that innovate in drug development, molecular diagnostics, genomic medicine, and bioprocessing to help advance human health. Operating through multiple strategic platforms and with nearly 63,000 employees, Danaher develops technologies and solutions for researchers, biopharmaceutical producers, and healthcare systems globally.

1 investor

DataBiologics provides a platform for medical practices to collect and leverage verified patient outcome data for marketing and practice growth. The platform helps clinics demonstrate treatment efficacy to prospective patients through validated surveys, competitive benchmarking, and HIPAA-compliant aggregate data sharing.

1 investor

Datamonk provides a platform that reads, analyzes, and corrects medical imaging metadata across DICOM hierarchies using deterministic rules and AI validation to ensure data quality for clinical teams. The platform standardizes imaging data across languages, vendors, and naming conventions, targeting healthcare systems and medical imaging archives.

1 investor

Datar Cancer Genetics is a healthcare company focused on cancer diagnostics and genetics. The company provides statutory investor relations information and annual reports for shareholders.

1 investor

Daxiang Bio develops organ-on-chip systems that recreate organ physiology and pathology in vitro to enable drug response prediction and medical research. The technology is applied in pharmaceutical development and biomedical research.

1 investor

DayaMed provides a cloud-based platform for remote patient monitoring, chronic care management, and medication adherence that integrates with electronic health records and enables clinical teams to deliver coordinated care across multiple conditions. The platform serves healthcare providers and care teams managing chronic disease patients, combining connected medical devices, clinical workflows, and 24/7 US-based clinician support.

1 investor

The page is a bioMérieux blog article about tracking a Cyclospora cayetanensis outbreak in the United States, referencing its clinical diagnostic and wastewater surveillance products for community health and medical professionals.

1 investor

DBV Technologies develops the VIASKIN® patch, a non-invasive, skin-based immunotherapy technology for treating food allergies and other immunological disorders. The company is investigating applications including allergy treatment and vaccine delivery through epicutaneous immunotherapy.

1 investor

Duoseq offers a comprehensive cancer genomics assay that profiles both DNA and RNA from a single sample in one preparation, delivering mutations, expression, fusions, and clonotype data with sample-to-report turnaround in about two days. It is built for on-site lab use with robotic workflow automation and integrates directly with EPIC and other EHR systems.

1 investor

DDS Lab is a dental laboratory providing custom ceramics, dentures, partials, nightguards, and sleep apnea devices for dental offices. The company offers case tracking and customer portal services to support real-time collaboration between the lab and dental practices.

1 investor

DEBN develops drug-eluting biopsy needles that deliver antibiotics directly to the prostate during transrectal ultrasound-guided biopsy procedures, reducing post-procedure infectious complications. The medical device targets urologists and healthcare systems performing prostate cancer diagnosis.

1 investor